オープン アクセスを義務付けられた論文 - Chen, Min-Shan詳細
一般には非公開: 24 件
Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization
ZL Huang, J Luo, MS Chen, JQ Li, M Shi
Journal of Vascular and Interventional Radiology 22 (5), 702-709, 2011
委任: US National Institutes of Health
Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
LI Xu, ZW Peng, MS Chen, M Shi, YJ Zhang, RP Guo, XJ Lin, WY Lau
Journal of hepatology 63 (1), 122-130, 2015
委任: National Natural Science Foundation of China
Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort
AP Fang, PY Chen, XY Wang, ZY Liu, DM Zhang, Y Luo, GC Liao, ...
International journal of cancer 144 (11), 2823-2832, 2019
委任: National Natural Science Foundation of China
Advanced recurrent hepatocellular carcinoma: treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation
Z Peng, S Chen, M Wei, M Lin, C Jiang, J Mei, B Li, Y Wang, J Li, X Xie, ...
Radiology 287 (2), 705-714, 2018
委任: National Natural Science Foundation of China
MicroRNAs miR‐125b and miR‐100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters
HC Zhou, JH Fang, LR Shang, ZJ Zhang, Y Sang, L Xu, Y Yuan, MS Chen, ...
The Journal of pathology 240 (4), 450-460, 2016
委任: National Natural Science Foundation of China
Microvascular invasion as a predictor of response to treatment with sorafenib and transarterial chemoembolization for recurrent intermediate-stage hepatocellular carcinoma
Z Peng, S Chen, H Xiao, Y Wang, J Li, J Mei, Z Chen, Q Zhou, S Feng, ...
Radiology 292 (1), 237-247, 2019
委任: National Natural Science Foundation of China
Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma
X Han, Y Gu, S Li, H Chen, M Chen, Q Cai, H Deng, M Zuo, J Huang
Journal of cancer research and clinical oncology 145, 303-312, 2019
委任: National Natural Science Foundation of China
Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
S Cheng, M Chen, J Cai
Oncotarget 8 (5), 8867-8876, 2017
委任: National Natural Science Foundation of China
Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: a preliminary …
S Li, J Mei, Q Wang, Z Guo, L Lu, Y Ling, L Xu, M Chen, L Zheng, W Lin, ...
Annals of Surgical Oncology 27, 5183-5190, 2020
委任: National Natural Science Foundation of China
Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case …
AK Bholee, K Peng, Z Zhou, J Chen, L Xu, Y Zhang, M Chen
Clinical and Translational Oncology 19, 844-852, 2017
委任: National Natural Science Foundation of China
Two‐year follow‐up of a randomized multicenter study comparing a drug‐coated balloon with a drug‐eluting stent in native small coronary vessels: the RESTORE small vessel …
J Tian, Y Tang, S Qiao, X Su, Y Chen, Z Jin, H Chen, B Xu, X Kong, ...
Catheterization and Cardiovascular Interventions 95, 587-597, 2020
委任: National Natural Science Foundation of China
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study
ZH Chen, XP Zhang, YG Lu, LQ Li, MS Chen, TF Wen, WD Jia, D Zhou, ...
Hepatology International 14, 754-764, 2020
委任: National Natural Science Foundation of China
Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: a double-blind randomized clinical trial
YX Pan, JC Wang, XY Lu, JB Chen, W He, JC Chen, XH Wang, YZ Fu, ...
Surgery 167 (6), 933-941, 2020
委任: National Natural Science Foundation of China
A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion
L Lu, W Wei, C Huang, S Li, C Zhong, J Wang, W Yu, Y Zhang, M Chen, ...
Hepatology international 15, 651-662, 2021
委任: National Natural Science Foundation of China
Comparison in prevalence, predictors, and clinical outcome of VSR versus FWR after acute myocardial infarction: the prospective, multicenter registry MOODY trial-heart rupture …
X Xue, J Kan, JJ Zhang, N Tian, F Ye, S Yang, H Qu, SL Chen, ...
Cardiovascular Revascularization Medicine 20 (12), 1158-1164, 2019
委任: National Natural Science Foundation of China
Comparison between portal vein perfusion chemotherapy and neoadjuvant hepatic arterial infusion chemotherapy for resectable intermediate to advanced stage hepatocellular carcinoma
Y Pan, J Mei, J Chen, D Zhang, J Wang, X Wang, M Yi, Z Zhou, Y Zhang, ...
Annals of surgical oncology, 1-14, 2022
委任: National Natural Science Foundation of China
Assessing hepatic fibrosis using 2-D shear wave elastography in patients with liver tumors: a prospective single-center study
Z Huang, W Zheng, YJ Zhang, L Xu, JB Chen, JC Chen, MS Chen, Z Zhou
Ultrasound in medicine & biology 43 (11), 2522-2529, 2017
委任: National Natural Science Foundation of China
Impact of intravascular ultrasound‐guided drug‐eluting stent implantation on patients with chronic kidney disease: results from ULTIMATE trial
J Zhang, X Gao, Z Ge, L Han, S Lu, X Qian, Q Li, Q Lu, C Chen, SL Chen, ...
Catheterization and Cardiovascular Interventions 93 (7), 1184-1193, 2019
委任: National Natural Science Foundation of China
Multi‐institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma
XH Wang, QB Liu, CL Xiang, XH Mao, B Yang, Q Li, QF Zhou, SQ Li, ...
International journal of cancer 149 (1), 127-138, 2021
委任: National Natural Science Foundation of China
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma
Z Yang, D Zhang, X Sima, Y Fu, H Zeng, Z Hu, J Hou, Y Pan, Y Zhang, ...
International Immunopharmacology 115, 109687, 2023
委任: National Natural Science Foundation of China
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます